News & media

ELEVAI LABS EXPANDS ADVISORY BOARD WITH THE ADDITION OF JAMES R. HEADLEY AS STRATEGIC ADVISOR

Mr. Headley, previously CEO of ZO Skin Health, will play an active role in supporting the ELEVAI management team as it evaluates strategic growth initiatives, product launches and partnerships. Headley will also leverage his extensive beauty industry background to support ELEVAI in business development and developing relationships with key opinion leaders in the aesthetic space.

Nov 1, 2022

ELEVAI LABS UNVEILS PARADIGM SHIFT SKINCARE TECHNOLOGY DURING GLOBAL AESTHETICS CONFERENCE

NEWPORT BEACH, Calif., Nov. 1, 2022 /PRNewswire/ — ELEVAI LABS, INC., a medical aesthetic biotechnology company specializing in regenerative skincare, announces its sponsorship and participation in the upcoming Global Aesthetics Conference taking place November 3-5 in Miami.

Sep 22, 2022

ELEVAI Labs, Inc. Announces Laboratory Expansion Allowing Fivefold Increase in Product Manufacturing Capabilities

The Company’s state-of-the-art lab and office space mark the 3rd expansion in 2 years, readying the company for further scalability to mass produce its first two SKUs under the E-Series umbrella; ELEVAI enfinity™ and ELEVAI empower™. The expansion effectively increases the Company’s production capabilities by approximately 500% and allows for continued R&D on the next wave of medical aesthetic products the company is developing.

August 17th, 2022

ELEVAI LABS, INC. Announces Appointment of Chris Kraneiss as Chief Commercial Officer

DAVIS, Calif., Aug. 17, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a science-based, data-driven regenerative aesthetic skincare company is pleased to announce the appointment of industry veteran Chris Kraneiss as Chief Commercial Officer. Mr. Kraneiss holds a proven track record of building successful medical aesthetic businesses within top globally recognized brands.

April 29th, 2022

ELEVAI LABS, INC. IS PLEASED TO ANNOUNCE THE APPOINTMENT OF BRENDA BUECHLER AS CHIEF MARKETING AND BRAND ADVISOR

Ms. Buechler has an extensive and successful career that spans over 23 years in director and leadership roles at companies including Alastin Skincare and SkinMedica. Ms. Buechler’s previous roles have included sales (B2C, B2B, and online), branding, and strategic marketing in start-ups as well as large established brands. Brenda is highly adept at building brands and developing marketing and communications strategies that exceed expectations and drive revenue.

Jan 25th, 2022

ELEVAI IS PLEASED TO ANNOUNCE IT HAS WON THE PEOPLES CHOICE AWARD AT THE 2022 OCTANE AESTHETICS TECH SUMMIT

Co-Founder and CEO, Jordan R. Plews, Ph.D., and his team were invited to present at this two-day event attended by hundreds of leaders in medicine, the aesthetic industry, and the business world to discuss innovative medical aesthetic technologies, as well as unmet clinical needs and new business opportunities.

Jan 21st, 2022

ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD

DAVIS, Calif., Jan. 21, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that it has signed a non-exclusive global distributor and trademark license agreement with leading Australian headquartered aesthetic device company DermapenWorld™ (“Dermapen”).

Jan 6th, 2022

2022 Aesthetics Tech Summit in Newport Beach, California

DAVIS, CALIFORNIA, Jan 06, 2022, ELEVAI LABS, INC., (“ELEVAI” or the “Company“) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that company co-founder and CEO, Jordan Plews, Ph.D., has been invited to present and speak at the 2022 Aesthetics Tech Summit on January 20 – 21 at the Balboa Bay Resort, 1221 West Coast Hwy, Newport Beach, CA 92663.  

Dec 21st, 2021

ELEVAI LABS, INC. Announces Launch of its E-SERIES Product Line

ELEVAI’s E-SERIES product line includes skincare formulations to support and enhance the results of in-office aesthetic procedures including micro-needling, laser resurfacing, microdermabrasion, and chemical peels. The E-SERIES products will be available only through selected dermatologists, plastic surgeons, and aestheticians in the United States.

Nov 1, 2022

ELEVAI LABS UNVEILS PARADIGM SHIFT SKINCARE TECHNOLOGY DURING GLOBAL AESTHETICS CONFERENCE

NEWPORT BEACH, Calif., Nov. 1, 2022 /PRNewswire/ — ELEVAI LABS, INC., a medical aesthetic biotechnology company specializing in regenerative skincare, announces its sponsorship and participation in the upcoming Global Aesthetics Conference taking place November 3-5 in Miami.

Sep 22, 2022

ELEVAI Labs, Inc. Announces Laboratory Expansion Allowing Fivefold Increase in Product Manufacturing Capabilities

The Company’s state-of-the-art lab and office space mark the 3rd expansion in 2 years, readying the company for further scalability to mass produce its first two SKUs under the E-Series umbrella; ELEVAI enfinity™ and ELEVAI empower™. The expansion effectively increases the Company’s production capabilities by approximately 500% and allows for continued R&D on the next wave of medical aesthetic products the company is developing.

August 17th, 2022

ELEVAI LABS, INC. Announces Appointment of Chris Kraneiss as Chief Commercial Officer

DAVIS, Calif., Aug. 17, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a science-based, data-driven regenerative aesthetic skincare company is pleased to announce the appointment of industry veteran Chris Kraneiss as Chief Commercial Officer. Mr. Kraneiss holds a proven track record of building successful medical aesthetic businesses within top globally recognized brands.

April 29th, 2022

ELEVAI LABS, INC. IS PLEASED TO ANNOUNCE THE APPOINTMENT OF BRENDA BUECHLER AS CHIEF MARKETING AND BRAND ADVISOR

Ms. Buechler has an extensive and successful career that spans over 23 years in director and leadership roles at companies including Alastin Skincare and SkinMedica. Ms. Buechler’s previous roles have included sales (B2C, B2B, and online), branding, and strategic marketing in start-ups as well as large established brands. Brenda is highly adept at building brands and developing marketing and communications strategies that exceed expectations and drive revenue.

Jan 25th, 2022

ELEVAI IS PLEASED TO ANNOUNCE IT HAS WON THE PEOPLES CHOICE AWARD AT THE 2022 OCTANE AESTHETICS TECH SUMMIT

Co-Founder and CEO, Jordan R. Plews, Ph.D., and his team were invited to present at this two-day event attended by hundreds of leaders in medicine, the aesthetic industry, and the business world to discuss innovative medical aesthetic technologies, as well as unmet clinical needs and new business opportunities.

Jan 21st, 2022

ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD

DAVIS, Calif., Jan. 21, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that it has signed a non-exclusive global distributor and trademark license agreement with leading Australian headquartered aesthetic device company DermapenWorld™ (“Dermapen”).

Jan 6th, 2022

2022 Aesthetics Tech Summit in Newport Beach, California

DAVIS, CALIFORNIA, Jan 06, 2022, ELEVAI LABS, INC., (“ELEVAI” or the “Company“) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that company co-founder and CEO, Jordan Plews, Ph.D., has been invited to present and speak at the 2022 Aesthetics Tech Summit on January 20 – 21 at the Balboa Bay Resort, 1221 West Coast Hwy, Newport Beach, CA 92663.  

Dec 21st, 2021

ELEVAI LABS, INC. Announces Launch of its E-SERIES Product Line

ELEVAI’s E-SERIES product line includes skincare formulations to support and enhance the results of in-office aesthetic procedures including micro-needling, laser resurfacing, microdermabrasion, and chemical peels. The E-SERIES products will be available only through selected dermatologists, plastic surgeons, and aestheticians in the United States.

Nov 1, 2022

ELEVAI LABS UNVEILS PARADIGM SHIFT SKINCARE TECHNOLOGY DURING GLOBAL AESTHETICS CONFERENCE

NEWPORT BEACH, Calif., Nov. 1, 2022 /PRNewswire/ — ELEVAI LABS, INC., a medical aesthetic biotechnology company specializing in regenerative skincare, announces its sponsorship and participation in the upcoming Global Aesthetics Conference taking place November 3-5 in Miami.

Sep 22, 2022

ELEVAI Labs, Inc. Announces Laboratory Expansion Allowing Fivefold Increase in Product Manufacturing Capabilities

The Company’s state-of-the-art lab and office space mark the 3rd expansion in 2 years, readying the company for further scalability to mass produce its first two SKUs under the E-Series umbrella; ELEVAI enfinity™ and ELEVAI empower™. The expansion effectively increases the Company’s production capabilities by approximately 500% and allows for continued R&D on the next wave of medical aesthetic products the company is developing.

August 17th, 2022

ELEVAI LABS, INC. Announces Appointment of Chris Kraneiss as Chief Commercial Officer

DAVIS, Calif., Aug. 17, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a science-based, data-driven regenerative aesthetic skincare company is pleased to announce the appointment of industry veteran Chris Kraneiss as Chief Commercial Officer. Mr. Kraneiss holds a proven track record of building successful medical aesthetic businesses within top globally recognized brands.

April 29th, 2022

ELEVAI LABS, INC. IS PLEASED TO ANNOUNCE THE APPOINTMENT OF BRENDA BUECHLER AS CHIEF MARKETING AND BRAND ADVISOR

Ms. Buechler has an extensive and successful career that spans over 23 years in director and leadership roles at companies including Alastin Skincare and SkinMedica. Ms. Buechler’s previous roles have included sales (B2C, B2B, and online), branding, and strategic marketing in start-ups as well as large established brands. Brenda is highly adept at building brands and developing marketing and communications strategies that exceed expectations and drive revenue.

Jan 25th, 2022

ELEVAI IS PLEASED TO ANNOUNCE IT HAS WON THE PEOPLES CHOICE AWARD AT THE 2022 OCTANE AESTHETICS TECH SUMMIT

Co-Founder and CEO, Jordan R. Plews, Ph.D., and his team were invited to present at this two-day event attended by hundreds of leaders in medicine, the aesthetic industry, and the business world to discuss innovative medical aesthetic technologies, as well as unmet clinical needs and new business opportunities.

Jan 21st, 2022

ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD

DAVIS, Calif., Jan. 21, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that it has signed a non-exclusive global distributor and trademark license agreement with leading Australian headquartered aesthetic device company DermapenWorld™ (“Dermapen”).

Jan 6th, 2022

2022 Aesthetics Tech Summit in Newport Beach, California

DAVIS, CALIFORNIA, Jan 06, 2022, ELEVAI LABS, INC., (“ELEVAI” or the “Company“) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that company co-founder and CEO, Jordan Plews, Ph.D., has been invited to present and speak at the 2022 Aesthetics Tech Summit on January 20 – 21 at the Balboa Bay Resort, 1221 West Coast Hwy, Newport Beach, CA 92663.  

Dec 21st, 2021

ELEVAI LABS, INC. Announces Launch of its E-SERIES Product Line

ELEVAI’s E-SERIES product line includes skincare formulations to support and enhance the results of in-office aesthetic procedures including micro-needling, laser resurfacing, microdermabrasion, and chemical peels. The E-SERIES products will be available only through selected dermatologists, plastic surgeons, and aestheticians in the United States.